
Sign up to save your podcasts
Or
Jennifer Quint, Thorax’s Journal Club editor, talks to David Jablons, University of California San Francisco, and consultant for Life Technologies, about his assay to predict survival in resected non-squamous, non-small-cell lung cancer.
See also:
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2811%2961941-7/abstract
4
11 ratings
Jennifer Quint, Thorax’s Journal Club editor, talks to David Jablons, University of California San Francisco, and consultant for Life Technologies, about his assay to predict survival in resected non-squamous, non-small-cell lung cancer.
See also:
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2811%2961941-7/abstract
40 Listeners
4 Listeners
52 Listeners
7 Listeners
5 Listeners
3 Listeners
4 Listeners
34 Listeners
11 Listeners
38 Listeners
14 Listeners
1 Listeners
48 Listeners
0 Listeners
6 Listeners
14 Listeners
3 Listeners
24 Listeners
23 Listeners
0 Listeners